Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
6115studies shown
Showing 1,381-1,392 of 6,115
Drug study icon
CompletedNCT06138691

KET-RO Plus RO DBT for Treatment Resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

In St Louis
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
Washington University School of Medicine
Condition
Depression
Drug study icon
CompletedNCT03947827

Minocycline as Adjunctive Treatment for Treatment Resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Toronto
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 80 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Depression
Device study icon
CompletedNCT03428828

Neurofeedback for Treatment Resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Pittsburgh
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 55 Years
Countries
United States
Sponsor
Kymberly Young
Condition
Depression
Drug study icon
CompletedNCT05066672

NV-5138 for treatment-resistant depression

This study is completed in the United States. It is testing NV-5138 for treatment-resistant depression.

In Bellevue
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Navitor Pharmaceuticals, Inc.
Condition
Depression
Device study icon
CompletedNCT03953417

Accelerated Theta Burst in Treatment-Resistant Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Palo Alto
Why is this study shown?

This study is directly about Depression.

Depression, BipolarityDeviceFrom 18 Years to 80 Years
Countries
United States
Sponsor
Stanford University
Condition
Depression, Bipolarity
Drug study icon
Active Not RecruitingNCT06731621

Psilocybin for Treatment-Resistant Depression in Autism

This summary needs review. Please check the official study record and contact the research team for details.

In Toronto
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Depression
Drug study icon
Active Not RecruitingNCT05774665

Specialized Pro-resolving Lipid Mediators and Treatment Resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Atlanta
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Depression
Drug study icon
TerminatedNCT04249596

Tianeptine for Treatment Resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Stanford
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 21 Years to 60 Years
Countries
United States
Sponsor
Jonathan A. Javitch, MD, PhD
Condition
Depression
Drug study icon
Not recruitingISRCTN44111488

Dose Escalation Legitimate? Pharmacology and Imaging studies in depression

This study is testing a medication approach for people with Depression, depression, Mental and Behavioural Disorders, or Depressive episode. Participants receive a study treatment and complete follow-up visits and assessments.

In Netherlands
Why is this study shown?

This study is directly about Depression.

DepressionOtherOver 18 Years
Countries
Netherlands
Sponsor
Academic Medical Centre (AMC) (Netherlands)
Condition
Depression
Drug study icon
Not recruitingISRCTN71745131

Improving emotion regulation in depression using real-time fMRI-based neurofeedback

This study is looking at care and outcomes for people with diagnosed with mild to moderate unipolar depression or Mental and Behavioural Disorders. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

In Switzerland
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 65 Years
Countries
Switzerland
Sponsor
University of Zurich
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.